Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32.4M | $40.4M | $42.0M | $48.3M | $45.6M | $52.5M | $55.6M | $66.6M |
| Revenue growth | — | 24.5% | 3.9% | 15.1% | -5.7% | 15.3% | 5.9% | 19.7% |
| Gross profit | — | — | — | — | — | $29.5M | $33.1M | $38.8M |
| Gross margin | — | — | — | — | — | 56.1% | 59.5% | 58.3% |
| Operating income | -$4.88M | -$9.30M | -$15.2M | -$24.1M | -$46.1M | -$22.8M | -$13.6M | -$14.1M |
| Operating margin | -15.0% | -23.0% | -36.2% | -49.8% | -101.1% | -43.5% | -24.5% | -21.1% |
| Net income | -$8.01M | -$12.0M | -$16.7M | -$26.9M | -$47.4M | -$23.7M | -$15.1M | -$20.0M |
| Net margin | -24.7% | -29.8% | -39.8% | -55.6% | -104.0% | -45.1% | -27.2% | -30.0% |
| EPS (diluted) | -$293.34 | -$8.46 | -$1.32 | -$1.68 | -$2.77 | -$1.34 | -$0.83 | -$0.93 |
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9.30M | -$9.71M | -$14.1M | -$20.3M | -$32.1M | -$14.5M | -$13.3M | -$13.6M |
| Capital expenditures | $199K | $403K | $455K | $2.37M | $4.32M | $828K | $515K | $641K |
| Free cash flow | -$9.50M | -$10.1M | -$14.5M | -$22.6M | -$36.5M | -$15.3M | -$13.8M | -$14.3M |
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13.2M | $72.1M | $57.4M | $99.4M | $62.4M | $36.5M | $22.0M | $32.2M |
| Total assets | $28.9M | $88.3M | $78.4M | $123M | $86.2M | $56.9M | $44.7M | $58.0M |
| Total liabilities | $35.6M | $32.7M | $36.5M | $38.5M | $43.8M | $34.3M | $35.1M | $40.6M |
| Long-term debt | $24.6M | $25.9M | $26.7M | $27.5M | $28.8M | $19.2M | $19.8M | $22.3M |
| Shareholders' equity | -$112M | $55.7M | $41.8M | $84.9M | $42.5M | $22.7M | $9.54M | $17.4M |
| Retained earnings | -$153M | -$165M | -$181M | -$208M | -$256M | -$279M | -$294M | -$314M |
| Shares (wtd avg diluted) | 63.0B | 12.6M | 12.6M | 16.0M | 17.1M | 17.7M | 18.2M | 21.6M |
Every figure is extracted from EXAGEN INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.